Ainslie Little

Ainslie Little, Ph.D., leads BlueRock’s strategy functions, including Business Development, Portfolio Strategy, New Product Planning, and Alliance Management. Ainslie joined BlueRock in 2017 to build BlueRock’s Intellectual Property portfolio and has since served as a leading member of business deals, partnerships, and strategic initiatives. Previously, Ainslie practiced at leading law firms in the United States and Canada with a focus on patent drafting, prosecution, and strategy. Ainslie contributed to protecting some of the foundational IP in cell therapy, including iPSC reprogramming, PSC manufacturing, and generation of authentic neural, cardiac and immune cells.